Ушбу иш иқтибос қилган ишлар

156 та иш

Иш: The interactions of docetaxel with tumor microenvironment

Abscopal effect in radioimmunotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +3
Шарҳ мақола20207 иқтибос
ABI
The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +2
Шарҳ мақола20207 иқтибос
ABI
Nobiletin as an inducer of programmed cell death in cancer: a review
Jun Huang, Zaoshang Chang, Quzhe Lu +2
Шарҳ мақола20226 иқтибос
ABI
Damage-associated molecular patterns in tumor radiotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa +2
Шарҳ мақола20205 иқтибос
ABI
Targeting of the tumor immune microenvironment by metformin
Zihong Wu, Caidie Zhang, Masoud Najafi
Шарҳ мақола20215 иқтибос
ABI
Targeting HIF-1 for cancer therapy
Gregg L. Semenza
Шарҳ мақола20034 иқтибос
ABI
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents
Run Yang, Changming Tan, Masoud Najafi
Шарҳ мақола20214 иқтибос
ABI
The interactions of paclitaxel with tumour microenvironment
Ding‐Li Yu, Zhiping Lou, Fengyun Ma +1
Шарҳ мақола20224 иқтибос
ABI
Redox Interactions in Chemo/Radiation Therapy-induced Lung Toxicity; Mechanisms and Therapy Perspectives
Xixi Lai, Masoud Najafi
Шарҳ мақола20224 иқтибос
ABI
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
Santosh Kumar Singh, James W. Lillard, Rajesh Singh
Мақола20183 иқтибос
ABI
RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi +11
Шарҳ мақола20213 иқтибос
ABI
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang +1
Шарҳ мақола20223 иқтибос
ABI
Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review
Peyman Amini, Reza Moazamiyanfar, Mohammad Sedigh Dakkali +7
Шарҳ мақола20223 иқтибос
ABI
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy
Guru Sonpavde, Phillip Periman, D. M. Bernold +8
Мақола20092 иқтибос
ABI
A Calcium Influx Pathway Regulated Separately by Oxidative Stress and ADP-Ribose in TRPM2 Channels: Single Channel Events
Mustafa Nazıroğlu, Andreas Lückhoff
Мақола20082 иқтибос
ABI
Mechanisms of Drug-Induced Mitotic Catastrophe in Cancer Cells
José Portugal, Sylvia Mansilla, Marc Bataller
Шарҳ мақола20092 иқтибос
ABI
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan +11
Мақола20162 иқтибос
ABI
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
Heba Alshaker, Qi Wang, Yoshiaki Kawano +5
Мақола20162 иқтибос
ABI
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
Karen A. Autio, Robert Dreicer, Justine Anderson +13
Мақола20182 иқтибос
ABI
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer
Wei Guan, Junhui Hu, Lu Yang +6
Мақола20182 иқтибос
ABI
The role of cytokines in the regulation of NK cells in the tumor environment
Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović +2
Шарҳ мақола20192 иқтибос
ABI
Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer
Xiaofen Lu, Tengteng Meng
Мақола20192 иқтибос
ABI
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw, Lalita A. Shevde
Шарҳ мақола20192 иқтибос
ABI
Mechanisms of immune evasion in bladder cancer
Paul L. Crispen, Sergei Kusmartsev
Шарҳ мақола20192 иқтибос
ABI
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Шарҳ мақола20202 иқтибос
ABI